Winton Group LTD Emergent Bio Solutions Inc. Transaction History

Winton Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$36.48 - $52.22 $1.44 Million - $2.06 Million	-39,524 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$33.11 - $55.01 $1.31 Million - $2.17 Million	39,524 New	39,524 $1.72 Million
Q3 2018 Nov 02, 2018	SELL	$52.05 - $66.51 $289,241 - $369,596	-5,557 Closed	0 $0
Q2 2018 Aug 20, 2018	SELL	$48.33 - $55.64 $9,859 - $11,350	-204 Reduced 3.54%	5,557 $0
Q1 2018 May 21, 2018	BUY	$44.44 - $54.39 $256,018 - $313,340	5,761 New	5,761 $0

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $473M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.